ReviewFrontiers in endocrinology2026

Continuous glucose monitoring after discontinuation of incretin-based obesity pharmacotherapy: indirect evidence and a research framework for metabolic stability and weight maintenance.

Andrijana Koceva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.